Where does Daniel Yadegar work?

Daniel Yadegar is Co-Founder and Chief Medical Officer at Newpath Partners and Board director at Rinascera Therapeutics and Board director at DermBiont.

What does Daniel Yadegar invest in?

Daniel Yadegar invests in Biotech, Healthtech, Medical Devices.

What check size does Daniel Yadegar write?

Daniel Yadegar typically writes checks of $50K – $10M.

What boards does Daniel Yadegar sit on?

Daniel Yadegar holds tracked board seats at DermBiont, Rinascera Therapeutics.

Daniel Yadegar

Investor

Co-Founder and Chief Medical Officer at Newpath Partners · Board director at Rinascera Therapeutics · Board director at DermBiont

Writes $50K – $10M checks

Find your path to Daniel

6 people in our graph can introduce you to Daniel.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Thomas Cahill to introduce you to Daniel

You →Thomas · together at Newpath Partners →Daniel

Ask Jamie Chen to introduce you to Daniel

You →Jamie · 3 people · together at DermBiont →Daniel

Ask Sam Okafor to introduce you to Daniel

You →Sam · together at Newpath Partners →Daniel

Your email: the people you already email who know Daniel
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Daniel
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Daniel Yadegar is a triple board‑certified cardiologist who embeds clinical leadership into fund management as co‑founder and CMO, while leading multiple healthcare platforms, serving on public boards, and practicing clinically.

Invests in

BiotechHealthtechMedical Devices

Board director at Rinascera Therapeutics

Intro paths

→

In turn, Daniel can intro founders to Rinascera Therapeutics's investors below.

Rinascera Therapeutics's investors · 1

Newpath PartnersBoston · $50K – $10M checks · since 2025

Board director at DermBiont

Intro paths

→

In turn, Daniel can intro founders to DermBiont's investors below.

DermBiont's investors · 8

Civilization Ventures Management, LlcTiburon · $1M – $10M checks Joyance PartnersBerlin Newpath PartnersBoston · $50K – $10M checks · since 2023 Olive Tree CapitalBoston Pivotal Life SciencesSan Francisco · since 2021 Start Capital Toba CapitalLos Angeles · $1M – $10M checks Valia VenturesLondon · $50K – $50M checks

Co-founders at DermBiont

Robert BruckerExecutive Officer

Deals · 2

Rinascera TherapeuticsBoard seat

via Newpath Partners · filed Oct 2025 · $2.5M raise

DermBiontBoard seat

via Newpath Partners · filed Nov 2024 · $45.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Leave your own feedback

Colleagues at Newpath Partners

Thomas Cahill

Managing Partner at Newpath Partners

Tom Thomas

Principal at Newpath Partners

Frequently asked questions

Who is Daniel Yadegar?: Daniel Yadegar is a triple board‑certified cardiologist who embeds clinical leadership into fund management as co‑founder and CMO, while leading multiple healthcare platforms, serving on public boards, and practicing clinically.
Where does Daniel Yadegar work?: Daniel Yadegar is Co-Founder and Chief Medical Officer at Newpath Partners and Board director at Rinascera Therapeutics and Board director at DermBiont.
What does Daniel Yadegar invest in?: Daniel Yadegar invests in Biotech, Healthtech, Medical Devices.
What check size does Daniel Yadegar write?: Daniel Yadegar typically writes checks of $50K – $10M.
What boards does Daniel Yadegar sit on?: Daniel Yadegar holds tracked board seats at DermBiont, Rinascera Therapeutics.